Brooklyn FI LLC purchased a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 8,906 shares of the financial services provider's stock, valued at approximately $738,000.
Several other large investors have also recently added to or reduced their stakes in the company. Ball & Co Wealth Management Inc. acquired a new stake in shares of MetLife during the 4th quarter valued at about $25,000. Transce3nd LLC acquired a new stake in MetLife during the fourth quarter valued at approximately $26,000. Quarry LP bought a new stake in shares of MetLife in the 4th quarter valued at approximately $31,000. Sierra Ocean LLC acquired a new position in shares of MetLife in the 4th quarter worth approximately $32,000. Finally, Graney & King LLC bought a new position in shares of MetLife during the 4th quarter worth approximately $34,000. Institutional investors and hedge funds own 94.99% of the company's stock.
MetLife Price Performance
Shares of MetLife stock traded down $0.34 during midday trading on Friday, reaching $78.52. The company had a trading volume of 4,359,385 shares, compared to its average volume of 3,411,203. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The stock has a fifty day simple moving average of $76.40 and a 200 day simple moving average of $81.00. MetLife, Inc. has a 1-year low of $65.21 and a 1-year high of $89.05. The company has a market capitalization of $52.71 billion, a price-to-earnings ratio of 13.15, a price-to-earnings-growth ratio of 0.65 and a beta of 0.85.
MetLife (NYSE:MET - Get Free Report) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.96 EPS for the quarter, missing the consensus estimate of $2.00 by ($0.04). MetLife had a net margin of 6.19% and a return on equity of 20.42%. The firm had revenue of $18.57 billion during the quarter, compared to analyst estimates of $18.06 billion. During the same period last year, the business posted $1.83 earnings per share. The firm's quarterly revenue was up 15.6% on a year-over-year basis. As a group, equities research analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife announced that its Board of Directors has approved a stock repurchase program on Wednesday, April 30th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to buy up to 5.9% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.
MetLife Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 10th. Shareholders of record on Tuesday, May 6th will be issued a dividend of $0.5675 per share. This is a boost from MetLife's previous quarterly dividend of $0.55. This represents a $2.27 annualized dividend and a yield of 2.89%. The ex-dividend date of this dividend is Tuesday, May 6th. MetLife's payout ratio is currently 36.91%.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on MET shares. JPMorgan Chase & Co. lowered their price target on MetLife from $88.00 to $86.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 2nd. Piper Sandler upped their target price on shares of MetLife from $92.00 to $94.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. Wall Street Zen downgraded shares of MetLife from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Barclays decreased their price objective on shares of MetLife from $95.00 to $88.00 and set an "overweight" rating on the stock in a research note on Friday, April 11th. Finally, Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $98.00 to $95.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to MarketBeat.com, MetLife presently has a consensus rating of "Moderate Buy" and a consensus price target of $94.17.
Read Our Latest Research Report on MET
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.